-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QbooNc/jtIwV0cjtN5nJHFaJAnCknjjqhSJpHVT07THSsHFAy1wBufNM4uUzNOAE WCXJfGbWpV862il5So0Isw== 0000904454-04-000374.txt : 20040528 0000904454-04-000374.hdr.sgml : 20040528 20040528145657 ACCESSION NUMBER: 0000904454-04-000374 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20040421 FILED AS OF DATE: 20040528 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: JOHNSON & JOHNSON DEVELOPMENT CORP ET AL CENTRAL INDEX KEY: 0000924020 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-50677 FILM NUMBER: 04838194 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: JOHNSON & JOHNSON CENTRAL INDEX KEY: 0000200406 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] STATE OF INCORPORATION: NJ FISCAL YEAR END: 0103 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-50677 FILM NUMBER: 04838195 BUSINESS ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 BUSINESS PHONE: 7325242454 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IMMUNICON CORP CENTRAL INDEX KEY: 0001083132 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] BUSINESS ADDRESS: STREET 1: 3401 MASONS MILL RD STREET 2: SUITE 100 CITY: HUNTINGTON VALLEY STATE: PA ZIP: 19006 BUSINESS PHONE: 215 830 0777 X121 4/A 1 edgar.xml PRIMARY DOCUMENT X0202 4/A 2004-04-21 2004-04-23 0001083132 IMMUNICON CORP IMMC 0000200406 JOHNSON & JOHNSON ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933 0 0 1 0 0000924020 JOHNSON & JOHNSON DEVELOPMENT CORP ET AL ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933 0 0 1 0 Common Stock 2004-04-21 4 C 0 1753236 A 1758236 I By Johnson & Johnson Development Corporation Series E Preferred Stock 2004-04-21 4 C 0 1054853 D Common Stock 703236 0 I By Johnson & Johnson Development Corporation Series F Preferred Stock 2004-04-21 4 C 0 1575000 D Common Stock 1050000 0 I By Johnson & Johnson Development Corporation The securities reported as being indirectly beneficially owned by the Reporting Person are directly beneficially owned by Johnson & Johnson Development Corporation, a wholly-owned subsidiary of the Reporting Person. All of the outstanding shares of the Issuer's Series E Convertible Preferred Stock were automatically converted on a 1-for-1.5 basis into Common Stock of the Issuer upon the closing of the Issuer's initial public offering. All of the outstanding shares of the Issuer's Series F Convertible Preferred Stock were automatically converted on a 1-for-1.5 basis into Common Stock of the Issuer upon the closing of the Issuer's initial public offering. The reported transactions are not new or revised but are being reported again to gain access to the system to file this amendment, the sole purpose of which is to add Johnson & Johnson Development Corporation as a joint filer. Michael H. Ullman, Secretary 2004-05-27 Eric B. Jung, Secretary 2004-05-27 -----END PRIVACY-ENHANCED MESSAGE-----